Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 247 followers
Latest posts
Last updated 10 minutes ago
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 20, Status: Authorised
16 minutes ago
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation...
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Alkindi, hydrocortisone, Date of authorisation: 09/02/2018, Revision: 10, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Alkindi, hydrocortisone, Date of authorisation...
Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Date of authorisation: 13/03/2001, Revision: 48, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Date of authorisation...
Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of...
Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation...
Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol, Date of authorisation...
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 23, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation...
Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application withdrawn
about 22 hours ago
Human medicines European public assessment report (EPAR): Izelvay, avacincaptad pegol, Status: Application...